About
Jaume Pons personally invented Ajovy (an anti‑CGRP antibody commercialized by Teva), led 13 protein therapeutics into human trials, and co‑founded ALX Oncology, taking it from inception through IPO.
Invests in
BiotechHealthtech
Colleagues at venBio Partners
Aaron Royston
Managing Partner at venBio Partners
Corey Goodman
Co-founder and Managing Partner at venBio Partners
Daniel Teichmann
Controller at venBio Partners
David Pezeshki
Chief Financial Officer at venBio Partners
Parthiv Patel
Analyst at venBio Partners
Richard Gaster
Managing Partner at venBio Partners
Robert Adelman
Co-founder and Emeritus Managing Partner at venBio Partners
Yvonne Yamanaka
Partner at venBio Partners